The total outlay for both schemes over the period 2025-26 to 2028-29 is ₹15,034.50 crore, with the central government contributing ₹10,303.20 crore and the states covering ₹4,731.30 crore.
Related Posts
Mental distress following heart attack can increase risk of another cardiac event: Study
Post Views: 16 The researchers explained that damage to heart…
Trump’s Pharma Tariff Plan Could Spark Cost and Supply Shock
Post Views: 23 President Trump has proposed imposing tariffs of…
Looming Patent Cliff Puts Big Pharma Under Pressure
Post Views: 22 Big pharmaceutical firms face a looming “patent…